Literature DB >> 18182626

In reference to Bosma et al. The course of neurocognitive functioning in high-grade glioma patients.

Marta Maschio, Loredana Dinapoli, Alessia Zarabla, Bruno Jandolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18182626      PMCID： PMC2600832          DOI： 10.1215/15228517-2007-049

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  4 in total

Review 1.  Issues related to the pharmacological management of patients with brain tumours and epilepsy.

Authors:  Marta Maschio; Loredana Dinapoli; Alessia Zarabia; Bruno Jandolo
Journal:  Funct Neurol       Date:  2006 Jan-Mar

2.  Levetiracetam therapy in patients with brain tumour and epilepsy.

Authors:  Marta Maschio; Fiorenzo Albani; Agostino Baruzzi; Alessia Zarabla; Loredana Dinapoli; Andrea Pace; Alfredo Pompili; Carmine Maria Carapella; Emanuele Occhipinti; Bruno Jandolo
Journal:  J Neurooncol       Date:  2006-05-10       Impact factor: 4.130

3.  The course of neurocognitive functioning in high-grade glioma patients.

Authors:  Ingeborg Bosma; Maaike J Vos; Jan J Heimans; Martin J B Taphoorn; Neil K Aaronson; Tjeerd J Postma; Henk M van der Ploeg; Martin Muller; W Peter Vandertop; Ben J Slotman; Martin Klein
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

4.  Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.

Authors:  Martin Klein; Nadine H J Engelberts; Henk M van der Ploeg; Dorotheé G A Kasteleijn-Nolst Trenité; Neil K Aaronson; Martin J B Taphoorn; Hans Baaijen; W Peter Vandertop; Martin Muller; Tjeerd J Postma; Jan J Heimans
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422
  4 in total
  2 in total

1.  Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.

Authors:  Marta Maschio; L Dinapoli
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

2.  Brain tumor-related epilepsy.

Authors:  Marta Maschio
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.